• Home
  • Politics
  • Health
  • World
  • Business
  • Finance
  • Tech
  • More
    • Sports
    • Entertainment
    • Lifestyle
What's Hot

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025
Facebook Twitter Instagram
  • Contact
  • Privacy Policy
  • Terms & Conditions
Friday, May 9
Patriot Now NewsPatriot Now News
  • Home
  • Politics

    Security video shows brazen sexual assault of California woman by homeless man

    October 24, 2023

    Woman makes disturbing discovery after her boyfriend chases away home intruder who stabbed him

    October 24, 2023

    Poll finds Americans overwhelmingly support Israel’s war on Hamas, but younger Americans defend Hamas

    October 24, 2023

    Off-duty pilot charged with 83 counts of attempted murder after allegedly trying to shut off engines midflight on Alaska Airlines

    October 23, 2023

    Leaked audio of Shelia Jackson Lee abusively cursing staffer

    October 22, 2023
  • Health

    Disparities In Cataract Care Are A Sorry Sight

    October 16, 2023

    Vaccine Stocks—Including Pfizer, Moderna, BioNTech And Novavax—Slide Amid Plummeting Demand

    October 16, 2023

    Long-term steroid use should be a last resort

    October 16, 2023

    Rite Aid Files For Bankruptcy With More ‘Underperforming Stores’ To Close

    October 16, 2023

    Who’s Still Dying From Complications Related To Covid-19?

    October 16, 2023
  • World

    New York Democrat Dan Goldman Accuses ‘Conservatives in the South’ of Holding Rallies with ‘Swastikas’

    October 13, 2023

    IDF Ret. Major General Describes Rushing to Save Son, Granddaughter During Hamas Invasion

    October 13, 2023

    Black Lives Matter Group Deletes Tweet Showing Support for Hamas 

    October 13, 2023

    AOC Denounces NYC Rally Cheering Hamas Terrorism: ‘Unacceptable’

    October 13, 2023

    L.A. Prosecutors Call Out Soros-Backed Gascón for Silence on Israel

    October 13, 2023
  • Business

    Trump Announces First Post-Tariff Trade Deal

    May 8, 2025

    Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

    May 7, 2025

    Tyson Foods Announces It Will Bend The Knee To Trump Admin’s New Rules

    May 7, 2025

    Federal Reserve Holds Interest Rates Steady Despite Pressure From Trump

    May 7, 2025

    ‘Wait Them Out’: John Kennedy Tells Larry Kudlow One Lie He Suspects China’s Telling US

    May 7, 2025
  • Finance

    Ending China’s De Minimis Exception Brings 3 Benefits for Americans

    April 17, 2025

    The Trump Tariff Shock Should Push Indonesia to Reform Its Economy

    April 17, 2025

    Tariff Talks an Opportunity to Reinvigorate the Japan-US Alliance

    April 17, 2025

    How China’s Companies Are Responding to the US Trade War

    April 16, 2025

    The US Flip-flop Over H20 Chip Restrictions 

    April 16, 2025
  • Tech

    Cruz Confronts Zuckerberg on Pointless Warning for Child Porn Searches

    February 2, 2024

    FTX Abandons Plans to Relaunch Crypto Exchange, Commits to Full Repayment of Customers and Creditors

    February 2, 2024

    Elon Musk Proposes Tesla Reincorporates in Texas After Delaware Judge Voids Pay Package

    February 2, 2024

    Tesla’s Elon Musk Tops Disney’s Bob Iger as Most Overrated Chief Executive

    February 2, 2024

    Mark Zuckerberg’s Wealth Grew $84 Billion in 2023 as Pedophiles Target Children on Facebook, Instagram

    February 2, 2024
  • More
    • Sports
    • Entertainment
    • Lifestyle
Patriot Now NewsPatriot Now News
Home»Health»FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative
Health

FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative

September 23, 2023No Comments3 Mins Read
Facebook Twitter Pinterest LinkedIn Tumblr Email
FDA Rejects Nasal Spray For Severe Allergic Reactions—Delaying First Needle-Free EpiPen Alternative
Share
Facebook Twitter LinkedIn Pinterest Email

Topline

The Food and Drug Administration on Tuesday declined to approve a nasal spray that would have been the first needle-free alternative to injectors like EpiPen for treating severe allergic reactions, a decision that “surprised” developer ARS Pharmaceuticals and could push back the anticipated treatment’s arrival until late next year.

The FDA declined to approve a nasal spray for severe allergic reactions.

getty

Key Facts

The FDA asked ARS Pharmaceuticals to conduct another study on its epinephrine nasal spray, Neffy, before it could be approved, according to a statement released by the company late on Tuesday.

The rejection came despite FDA advisors voting in favor of the regulator approving the drug for use in both adults and children in May and ARS Pharmaceuticals said it had come to an agreement with the regulator in August to collect the requested data on the safety of repeated doses once Neffy was on the market.

While the FDA is not legally bound to follow the votes of its committees, it is rare for the agency to deviate from their recommendations.

CEO Richard Lowenthal said the company is “very surprised” and “deeply disappointed” by the FDA’s decision and its “late” change of heart to require the study before approval, particularly given the endorsement from the agency’s advisory committee.

ARS Pharmaceuticals said it will appeal the FDA’s decision and plans to resubmit its application in the first half of 2024.

This timeline would give the FDA an “action date” for a response at some point in the second half of next year, ARS Pharmaceuticals said.

Key Background

Epinephrine, also known as adrenaline, has been used to treat allergic reactions for more than 100 years. The medicine can be lifesaving for those experiencing the most severe form of allergic reaction, anaphylaxis, which can come on suddenly after exposure to allergens like peanuts or shellfish and can kill without treatment. All treatment options for anaphylaxis on the market are injectable—often autoinjector pens like EpiPens that give a fixed single dose—which can spark fear or discomfort in some patients who are afraid of needles, can be impractical to carry around and are often prohibitively expensive. The potential life-threatening nature of anaphylaxis complicates the study of new drugs significantly and Neffy has not actually been tested in people experiencing anaphylaxis. This was a point of dispute among the FDA advisory panel—which nevertheless endorsed the drug—and the company collected alternative data to compare the drug to the injectors on the market. Its trials in healthy people, animals and people having a rhinitis attack, a type of allergic reaction in the nose, suggested the spray was comparable to injectors.

Crucial Quote

“I’m shocked,” Dr. Zachary Rubin, an allergist at Oak Brook Allergists in Illinois, told NBC News when asked about the FDA’s decision. Rubin, who was not on the FDA’s advisory committee, said “there are no alternatives” to needles for severe allergic reactions right now. “You basically have epinephrine autoinjector devices, needle options, and people have been clamoring for years to get a needle-free option,” Rubin said.

See also  Danaher Lowers Price Of Tuberculosis Test After Pressure Campaign
Allergic Alternative EpiPen FDA Nasal needlefree ReactionsDelaying Rejects Severe Spray
Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Related Posts

Can Changes in FDA Regulation Affect Your Beauty Products?

January 28, 2025

Google Rejects Eurocrats’ Push For More Censorship

January 16, 2025

Tucker Carlson Releases ALP Pouches As Alternative To Woke Zyn

November 14, 2024

China’s Alternative Global Trade System

April 30, 2024
Add A Comment

Leave A Reply Cancel Reply

Top Posts

China’s Draft Criminal Law Amendment Eyes Corruption in Private Firms

August 1, 2023

Adult Drag Queens Dance with Teens at ‘Alternate Prom’ Free from ‘Bulls**t Gender Dress Code’

July 31, 2023

Explicit Teenage Photos Allegedly Paid for by BBC Star Presenter

July 9, 2023

Cornell U. Professor Calls Hamas Terror Attack Against Israel ‘Exhilarating, Energizing’

October 18, 2023
Don't Miss

Trump Announces First Post-Tariff Trade Deal

Business May 8, 2025

President Donald Trump announced Thursday the U.S. has reached a trade agreement with the U.K.,…

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025

Electric Vehicle Sales Nosedive As GOP Takes Buzzsaw To Biden’s Mandate

May 7, 2025
About
About

This is your World, Tech, Health, Entertainment and Sports website. We provide the latest breaking news straight from the News industry.

We're social. Connect with us:

Facebook Twitter Instagram Pinterest
Categories
  • Business (4,110)
  • Entertainment (4,220)
  • Finance (3,202)
  • Health (1,938)
  • Lifestyle (1,626)
  • Politics (3,084)
  • Sports (4,036)
  • Tech (2,006)
  • Uncategorized (4)
  • World (3,944)
Our Picks

‘DWTS’ Judge Carrie Ann Inaba Says It’s ‘A Gift’ To Feel Pain After Emergency Surgery

April 4, 2023

AstraZeneca planning China business spin off, Financial Times reports

June 20, 2023

Karl Lagerfeld Documentary Acquired by Prime Video

April 28, 2023
Popular Posts

Trump Announces First Post-Tariff Trade Deal

May 8, 2025

100 Funny Father’s Day Quotes for Hilariously Relatable Humor (and Plenty of Love Too)

May 8, 2025

Top 10 Benefits Of Acupuncture

May 8, 2025
© 2025 Patriotnownews.com - All rights reserved.
  • Contact
  • Privacy Policy
  • Terms & Conditions

Type above and press Enter to search. Press Esc to cancel.